نتائج البحث - P. D. Home
- يعرض 1 - 5 نتائج من 5
-
1
-
2
-
3
Experience of malignancies with oral glucose-lowering drugs in the randomised controlled ADOPT (A Diabetes Outcome Progression Trial) and RECORD (Rosiglitazone Evaluated for Cardio... حسب P. D. Home, Steven E. Kahn, Nigel C. Jones, Drusilla Noronha, Henning Beck‐Nielsen, Giancarlo Viberti
منشور في 2010Artigo -
4
Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in Diabetes (RECORD): study design and protocol حسب P. D. Home, SJ Pocock, Henning Beck‐Nielsen, Ramón Gomis, M Hanefeld, Henry Dargie, Michel Komajda, J. Gubb, N. Biswas, Nicholas P. Jones
منشور في 2005Artigo -
5
Heart failure events with rosiglitazone in type 2 diabetes: data from the RECORD clinical trial حسب Michel Komajda, John J.V. McMurray, Henning Beck‐Nielsen, Ramón Gomis, M Hanefeld, S J Pocock, Peter S. Curtis, Nigel C. Jones, P. D. Home
منشور في 2010Artigo
أدوات البحث:
موضوعات ذات صلة
Endocrinology
Internal medicine
Medicine
Diabetes mellitus
Insulin
Rosiglitazone
Type 2 diabetes
Adverse effect
Clinical trial
Metformin
Anesthesia
Biochemistry
Cancer
Cardiology
Centrifugation
Chemistry
Chromatography
Clinical endpoint
Confidence interval
Economics
Environmental health
Extraction (chemistry)
Finance
Glibenclamide
Gliclazide
Glycemic
Hazard ratio
Heart failure
Incubation
Incubation period